Low SOX2 expression marks a distinct subset of adenoid cystic carcinoma of the head and neck and is associated with an advanced tumor stage.

PLoS One · 2018 · PMC5875788 · PMID 29596469

Europe PMC DOI

hedged sentences

0.0670

closest p · 1.3× alpha

0.0840

boldest claim

The sentences

a clear trendp = 0.067so close (0.05 < p ≤ 0.1)

Interestingly, SOX2 expression was significantly higher in patients without lymph node metastasis as compared to their N+ counterparts (p = 0.047), and a clear trend of higher SOX2 expression in patients with a lower tumor stage (p = 0.067) was observed.

also in 19,460 other papers

showed a trendp = 0.084so close (0.05 < p ≤ 0.1)

Patients diagnosed with a solid tumor type showed a trend towards poor clinical outcome ( Fig 1A , p = 0.084) and that parotideal HNACC had a better overall survival ( Fig 1B , p = 0.003), which is in line with findings of other studies [ 8 ], [ 9 ].

also in 53,322 other papers

did not reach statistical significanceno p-value reported

However, the correlation between SOX2, vimentin or E-cadherin did not reach statistical significance ( S1 Table ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.